(Q39176615)

9 September 2017

title

Antimalarial Drug Resistance: A Threat to Malaria Elimination (English)

1 reference

9 September 2017

0 references

0 references

1

1 reference

9 September 2017

Arjen Dondorp

2

1 reference

9 September 2017

publication date

13 March 2017

1 reference

Cold Spring Harbor Perspectives in Medicine

9 September 2017

published in

1 reference

9 September 2017

volume

7

1 reference

9 September 2017

issue

7

1 reference

Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Artemisinin resistance in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Spread of artemisinin resistance in Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

A new high-throughput method for simultaneous detection of drug resistance associated mutations in Plasmodium vivax dhfr, dhps and mdr1 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Dose-dependent risk of neutropenia after 7-day courses of artesunate monotherapy in Cambodian patients with acute Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Kinetic characterization of Na+/H+ antiport of Plasmodium falciparum membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Polymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Stage-specific activity of potential antimalarial compounds measured in vitro by flow cytometry in comparison to optical microscopy and hypoxanthine uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Lack of Artemisinin Resistance in Plasmodium falciparum in Uganda Based on Parasitological and Molecular Assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Mechanisms of in vitro resistance to dihydroartemisinin in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Factors determining water treatment behavior for the prevention of cholera in Chad

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Artemisinin Resistance in Plasmodium falciparum Malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Artemisinin resistance: current status and scenarios for containment

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Polymorphisms in Plasmodium falciparum K13-propeller in Angola and Mozambique after the introduction of the ACTs

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Dissecting the loci of low-level quinine resistance in malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Plasmodium falciparum multidrug resistance protein 1 (pfmrp1) gene and its association with in vitro drug susceptibility of parasite isolates from north-east Myanmar

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Slow Clearance of Plasmodium falciparum in Severe Pediatric Malaria, Uganda, 2011-2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

A Single Mutation in K13 Predominates in Southern China and Is Associated With Delayed Clearance of Plasmodium falciparum Following Artemisinin Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Novel mutations in K13 propeller gene of artemisinin-resistant Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

High recombination rates and hotspots in a Plasmodium falciparum genetic cross

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

K13-propeller polymorphisms in plasmodium falciparum parasites from sub-saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

An analytical method for assessing stage-specific drug activity in Plasmodium vivax malaria: implications for ex vivo drug susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Altered temporal response of malaria parasites determines differential sensitivity to artemisinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Decreasing pfmdr1 copy number suggests that Plasmodium falciparum in Western Cambodia is regaining in vitro susceptibility to mefloquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Towards real-time monitoring of artemisinin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Genetic architecture of artemisinin-resistant Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Multiple transporters associated with malaria parasite responses to chloroquine and quinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Parallel evolution of adaptive mutations in Plasmodium falciparum mitochondrial DNA during atovaquone-proguanil treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Counterfeit artesunate antimalarials in southeast Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Probing the multifactorial basis of Plasmodium falciparum quinine resistance: Evidence for a strain-specific contribution of the sodium-proton exchanger PfNHE

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Histidine-rich protein II: a novel approach to malaria drug sensitivity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Evidence of Artemisinin-Resistant Malaria in Western Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Probability of emergence of antimalarial resistance in different stages of the parasite life cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Disruption of a Plasmodium falciparum Multidrug Resistance-associated Protein (PfMRP) Alters Its Fitness and Transport of Antimalarial Drugs and Glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Plasmodium vivax resistance to chloroquine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Chemoresistance of P. falciparum in urban areas of Yaounde, Cameroon. Part 1: Surveillance of in vitro and in vivo resistance of Plasmodium falciparum to chloroquine from 1994 to 1999 in Yaounde, Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Spiroindolones, a potent compound class for the treatment of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Human ex vivo studies on asexual Plasmodium vivax: the best way forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Intrahost modeling of artemisinin resistance in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Approaches to malaria vaccine development using the retrospectroscope

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Dihydroartemisinin-piperaquine failure in Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Evolution from double to triple-antimalarial drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Plasmodium parasites mount an arrest response to dihydroartemisinin, as revealed by whole transcriptome shotgun sequencing (RNA-seq) and microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Direct evidence for the atovaquone action on the Plasmodium cytochrome bc1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Antimalarial drug resistance in Africa: key lessons for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Phenotypic changes in artemisinin-resistant Plasmodium falciparum lines in vitro: evidence for decreased sensitivity to dormancy and growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Human malaria parasites in continuous culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Impact of chloroquine resistance on malaria mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Malaria medicines: a glass half full?

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Qinghaosu (Artemisinin): The Price of Success

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Real-time PCR methods for monitoring antimalarial drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

High-throughput analysis of antimalarial susceptibility data by the worldwide antimalarial resistance network (WWARN) In Vitro analysis and reporting tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

Access to artemisinin combination therapy for malaria in remote areas of Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025619

The public health impact of chloroquine resistance in Africa

21 January 2018

1 reference

12 December 2020

Evaluation of in vitro drug sensitivity of antimalarials for Plasmodium falciparum using a colorimetric assay (DELI-microtest)

1 reference

12 December 2020

Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3- hydroxy-1,4-naphthoquinone (566C80)

1 reference

12 December 2020

DRUG RESISTANCE IN PLASMODIUM FALCIPARUM FROM THAILAND.

1 reference

12 December 2020

PLASMODIUM FALCIPARUM RESISTANT TO CHLOROQUINE IN CAMBODIA.

1 reference

12 December 2020

Antimalarial drug resistance

1 reference

12 December 2020

Plasmodium falciparum susceptibility to antimalarial drugs: global data issued from the Pasteur Institutes international network

1 reference

12 December 2020

Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis

1 reference

12 December 2020

(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium.

1 reference

12 December 2020

Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network

1 reference

12 December 2020

Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine

1 reference

12 December 2020

Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia

1 reference

12 December 2020

Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand

1 reference

12 December 2020

Type II mefloquine resistance in Thailand

1 reference

12 December 2020

Sulfadoxine-pyrimethamine resistant falciparum malaria from Cambodia

1 reference

12 December 2020

Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique

1 reference

12 December 2020

Ten-year surveillance of drug-resistant malaria in Burkina Faso (1982-1991).

1 reference

12 December 2020

Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia

1 reference

12 December 2020

Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon.

1 reference

12 December 2020

10.1101/CSHPERSPECT.A025619

Identifiers

DOI

1 reference

9 September 2017

0 references

1 reference